Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"novel transcript, antisense to IMPDH1" (ENSG00000294385) refers to a predicted or uncharacterized noncoding RNA, located on the antisense strand relative to the well-characterized IMPDH1 gene. There is currently no experimental evidence for a protein product, established molecular function, role in disease, or clinical relevance. This entry is a bioinformatic annotation found in genome databases, typically representing a region of transcription observed in sequencing data but not confirmed or functionally annotated. It is not considered a therapeutic target, receptor, enzyme, or similar functional molecule. This entity should not be confused with IMPDH1 itself, which is a well-characterized enzyme involved in nucleotide metabolism and associated with several inherited retinopathies[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to IMPDH1.